Margaret R Lentz1, Anna N Honko1, Jordan K Bohannon1, Matthew G Lackemeyer1, Jeffrey M Solomon2, Louis M Huzella1, Gene G Olinger1, Lisa E Hensley1, and Peter B Jahrling1,3
1NIAID/Integrated Research Facility, National Institutes of Health, Frederick, MD, United States, 2Clinical Research Directorate & Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., Frederick, MD, United States, 3NIAID, Emerging Viral Pathogens Section, National Institutes of Health, Frederick, MD, United States
Synopsis
The purpose of this study
was to use MRI and magnetic resonance spectroscopy (MRS) to determine if
structural or metabolic alterations occur in the brain of rhesus macaques
exposed to Ebola virus via inhalation of aerosolized small particles. Unlike intramuscular
inoculation with Ebola virus, small-particle aerosol exposure of macaques did not
result in uniform changes in brain volume or vascular alterations 8-9 days
after exposure. However, most animals had reductions in N-acetyl
aspartate and increases in choline levels, indicating spectroscopy may be
useful in identifying early alterations in brain metabolism due to Ebola virus
disease.
Purpose
Signs of neurologic disease
are difficult to identify in nonhuman primate models of Ebola virus
infection. The use of magnetic resonance
imaging (MRI) can provide insight to possible structural and metabolic changes
occurring during Ebola virus infection. Our
previous studies indicated that macaques exposed to 1,000 plaque forming units
of Ebola virus (EBOV) by intramuscular injection had significant reductions in
whole brain volumes (N=6, -3.3%, p<0.0001), enlarged brain ventricles, as
well as alterations in the susceptibility weighted imaging (SWI) indicative of
vascular congestion within 7-8 days of exposure[1]. The purpose of the current
study was to use MRI and magnetic resonance spectroscopy (MRS) to determine if
structural or metabolic alterations occur in the brain of rhesus macaques exposed
to Ebola virus via inhalation of aerosolized small particlesMethods
Ten rhesus macaques were
exposed to EBOV (Makona variant) via small particle aerosol challenge. Averaged
inhaled dose 1150 pfu, with particle size ranging 0.5-3.0 mm. Seven of these animals underwent imaging
before exposure and just prior to euthanasia (8-9 days post exposure). Neuroimaging
was performed using a clinical 3T Achieva MRI using a pediatric SENSE
Head-Spine coil (Philips Healthcare, Andover, MA). Structural brain imaging
included: T1-weighted magnetization prepared rapid acquisition with
gradient echo (MPRAGE), R2* and T2-weighted
images. A 3D MPRAGE sequence
was performed that included the following parameters: in-plane resolution of
0.5x0.5x0.5 mm3, TR/TE=9.8/4.7 ms, TI=1100 ms, NSA=2, flip angle of
8o, TFE factor=96, time=4.5 min, and a FOV 96x96x68 mm3. Based
on the principle of echo shifting technique [2], a 3D sequence to produce R2*
images was created with the following parameters: in-plane resolution of 0.5x0.5x0.5
mm3, TR/TE of 27/35 ms, NSA = 1, flip angle = 5o, time=6
min, and a FOV 96x96x68 mm3. A turbo spin echo (TSE) sequence was used
to generate T2-weighted images, which included the following parameters: in-plane
resolution of 0.4x0.4 mm2, 2 mm slice thickness, TR/TE=7974/80 ms,
NSA=1, fat suppression (SPIR), TSE factor=12, time=4.5 min, and a FOV 96x96x68
mm3. MRS was used to examine changes in brain
metabolism in a 1 cm3 region of the gray matter in the fontal cortex.
Parameters included: TR/TE=2500/35 ms, the use of a point resolved
spectroscopy, 128 averages, chemical shift selective water suppression and the
use of 2nd ordered shims. Spectra were fit using LCModel [3]. Paired t-tests were used to determine significant
differences between pre and post-exposure metabolite values observed by MRS.
Results
Of the seven animals imaged, only one
exhibited reduced brain volume and enlarged ventricles (Figure 1A). Two more animals
had indications of vascular changes in the R2* images, one of
which was not due to vascular congestion but a focal acute hemorrhage that
occurred in the left brain ventricle (Figure 1B). No other significant
lesions could be identified by imaging or histologically. While structural MRI
can be a useful tool, MRS is far more sensitive, allowing for the detection of
neuronal, glial and lipid metabolism that can occur before pathology is
evident. Within the frontal cortex (Figure 2), concentrations of N-acetyl
aspartate, a marker of neuronal integrity/injury, were found to be reduced in 6
of 7 animals after infection with EBOV/Makona (p<0.01, Figure 3).
Choline, a marker of lipid metabolism and suspected marker of glial activation,
was found to be elevated in 6 of 7 animals following exposure to EBOV/Mak (p<0.02,
Figure 3). Since no significant changes were observed in creatine
concentration (p = 0.10), the commonly used metabolite ratios of NAA to
creatine (NAA/Cr) and chloline to creatine (Cho/Cr) showed similar changes to
that observed in the NAA and choline absolute concentration (Figure 3).
Discussion & Conclusion
Unlike IM inoculation with
EBOV/Makona, small particle aerosol exposure of macaques to EVOB did not result
in uniform changes in brain volume or vascular alterations. However, in
many diseases, metabolic changes in tissues are known to precede structural
alterations. Reductions in NAA were
observed in the frontal cortex (6 of 7 animals), indicating either neuronal
injury or relaxation due to increased iron content (vascular congestion) is occurring.
Increases in choline levels (observed in 6 of 7 animals) are often attributed
to lipid membrane metabolism, glial activation or cellular infiltration in the
brain. Further pathologic assessment is required to determine the relationship
between alterations in brain metabolism and Ebola virus related disease. In regards to alterations in the brain, these
preliminary results indicate that differences exist between intramuscular and
aerosol exposure models. Moreover, MRS may be a useful tool in examining early
changes in brain metabolism due to Ebola virus disease.Acknowledgements
This
work was supported by NIAID Division of Intramural Research and NIAID DCR and
was performed under Battelle Memorial Institute contract (No.
HHSN272200700016I) with NIAID. Additional support was provided by the NCI
Contract No. HHSN261200800001E.References
[1] Lentz MR, et al. “Neuroimaging of Acute Ebola Virus Disease in
a Non-Human Primate Model”. International Society of Magnetic Resonance in
Medicine, Singapore, 2016.
[2] Moonen CTW, et al. Magn Reson Med. 1992; 26 (1): 184-189
[3] http://s-provencher.com/pages/lcmodel.shtml